BrightHeart View Classifier vs ASSURE Wearable ECG

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BrightHeart View Classifier

by BrightHeart

ASSURE Wearable ECG

by Kestra Medical Technologies

AI Verdict

Tool A is designed to enhance prenatal ultrasound exams for detecting congenital heart defects, providing real-time guidance and ensuring exam completeness. Tool B, on the other hand, is a wearable ECG device for continuous heart rate monitoring and data collection in at-risk cardiac patients, focusing on remote patient management. While both leverage AI in cardiology, their distinct applications in diagnostic imaging for fetal health versus remote monitoring for adult cardiac patients make them suitable for different clinical needs.

Choose BrightHeart View Classifier if…

Choose BrightHeart View Classifier if your primary goal is to enhance the accuracy and completeness of prenatal fetal heart ultrasound exams. This tool is ideal for maternal-fetal medicine specialists and OB/GYN practices seeking AI-powered real-time guidance to improve the detection of congenital heart defects and ensure consistent, high-quality screenings regardless of operator experience.

View BrightHeart View Classifier →

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you need a reliable solution for continuous, long-term heart rate monitoring and data collection for at-risk adult cardiac patients in an outpatient setting. This wearable device is best suited for cardiologists looking to remotely track patient cardiac activity, receive alert-based notifications, and analyze physiologic trend data through a dedicated digital healthcare platform.

View ASSURE Wearable ECG →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BrightHeart View Classifier	ASSURE Wearable ECG
Pricing	Unknown	Contact for pricing.
Deployment	Seamless integration into existing ultrasound workflows, plug and play solution, compatible with major ultrasound manufacturers and existing reporting solutions, automatic display on cart-side tablet during scan, results summarized and linked in reporting software, detailed assessments on standalone web platform.	Wearable device, mobile application, and cloud-based remote patient data platform.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Yes AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

BrightHeart View Classifier

Tool A offers real-time guidance via a cart-side tablet and integrates seamlessly as a plug-and-play solution into existing ultrasound workflows, directly enhancing the sonographer's experience during a complex procedure. Tool B focuses on patient comfort for its wearable and a separate clinician review platform, which is also user-friendly but less about real-time procedural guidance.

Clinical Value

BrightHeart View Classifier

Tool A directly enhances the detection of congenital heart defects and ensures exam completeness and consistency, addressing a critical diagnostic need with immediate and significant impact on patient outcomes. Tool B provides valuable continuous monitoring for at-risk cardiac patients, but Tool A's focus on improving the accuracy of a primary diagnosis for a severe condition gives it a slight edge in direct clinical impact.

Pricing & Value

Tie

Both tools have undisclosed pricing, making it impossible to conduct a head-to-head comparison on cost or to accurately assess their value proposition relative to their price. Without this crucial information, a definitive winner cannot be determined for this dimension.

Enterprise Readiness

ASSURE Wearable ECG

Tool B explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA), which are critical requirements for healthcare enterprises. While Tool A has FDA clearance and seamless integration, its public information does not explicitly confirm HIPAA compliance or BAA availability, giving Tool B a stronger documented position for enterprise adoption.

Innovation

BrightHeart View Classifier

Tool A demonstrates high innovation by providing real-time AI-powered guidance during live prenatal ultrasound exams, assisting in view acquisition and flagging potential abnormalities. This interactive, real-time application of AI in a complex diagnostic imaging procedure represents a significant advancement. Tool B's advanced wearable technology and algorithms for continuous monitoring are also innovative but build on existing remote patient monitoring concepts.

Support & Docs

Tie

Neither the provided structured facts nor readily available public information for either tool offer details regarding their support services or documentation. Without this information, it is impossible to differentiate between the two products on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BrightHeart View Classifier	ASSURE Wearable ECG
Company	BrightHeart	Kestra Medical Technologies
Primary Use Case	AI-powered guidance and analysis for prenatal ultrasound exams, enhancing the detection of congenital heart defects and ensuring exam completeness.	Non-therapeutic device for continuous heart rate monitoring and data collection for at-risk cardiac patients.
Target Specialties	Cardiology, Maternal-Fetal Medicine, Obstetrics & Gynecology	Cardiology
Core Technology/Methodology	AI-powered analysis of fetal heart ultrasound exams with real-time guidance and automatic view detection.	Wearable ECG device with continuous heart rate monitoring, SensorFit Garment, and ASSURE Detection Algorithm.

Videos

Demos, reviews, and walkthroughs featuring BrightHeart View Classifier and ASSURE Wearable ECG.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How does the BrightHeart View Classifier integrate into the existing prenatal ultrasound workflow, and what specific clinical benefits can physicians expect in terms of exam quality and detection of congenital heart defects?

The BrightHeart View Classifier integrates seamlessly as a plug-and-play solution, providing real-time, cart-side guidance and AI-powered analysis during prenatal ultrasound exams. It automatically detects and confirms standard fetal heart views, flags potential structural abnormalities, and ensures exam completeness, which can lead to a reduction in incomplete scans and patient recalls.

How does the ASSURE Wearable ECG integrate into a patient's daily life and a clinician's monitoring workflow, and what actionable insights does the Kestra CareStation platform provide for at-risk cardiac patients?

The ASSURE Wearable ECG is a continuous heart rate monitoring device worn by the patient, featuring a non-adhesive SensorFit Garment. It automatically stores cardiac episodes, provides alert-based notifications, and collects physiologic trend data, all accessible to clinicians through the Kestra CareStation remote patient data platform for review and proactive management.

How do the respective AI algorithms and detection technologies contribute to the accuracy and reliability of each tool's output, particularly regarding diagnostic confidence?

BrightHeart's B-Right AI Platform uses AI-powered analysis to automatically detect and confirm standard fetal heart views and flags potential structural abnormalities, demonstrating high sensitivity (98.7%) and specificity (97.7%) in detecting severe congenital heart defects. The ASSURE Detection Algorithm with Quad Channel Processingu2122 and Adaptive Patient Intelligenceu2122 filters motion artifacts, contributing to reliable continuous heart rate monitoring and accurate episode storage, with a reported sensitivity of 99.0% for VF and 98.4% for VT.

Beyond their primary specialties, what specific clinical scenarios or patient populations are most appropriately served by the unique capabilities of the BrightHeart View Classifier versus the ASSURE Wearable ECG?

BrightHeart View Classifier is best suited for maternal-fetal medicine and OB/GYN practices performing prenatal ultrasounds, aiming to improve the screening and early detection of congenital heart defects in fetuses. In contrast, the ASSURE Wearable ECG is designed for cardiology practices managing adult patients at risk for sudden cardiac arrest, requiring continuous, long-term heart rate monitoring and remote data collection for diagnostic and management purposes.

What is the expected learning curve for sonographers to adopt the BrightHeart View Classifier, and how quickly can a practice realize value in terms of improved efficiency and diagnostic quality?

As a plug-and-play solution that seamlessly integrates into existing ultrasound workflows, the BrightHeart View Classifier is designed for a minimal learning curve. Practices can quickly realize value through improved efficiency, reduced incomplete fetal heart scans, lower patient recall rates, and enhanced diagnostic quality by ensuring expert-level screening.

What is the depth of integration with existing reporting solutions or EHRs, and what audit-trail features are available to support clinical documentation and review for each tool?

BrightHeart is compatible with major ultrasound manufacturers and existing reporting solutions, ensuring exam completeness and consistency, which supports robust clinical documentation. The Kestra CareStation platform provides remote patient data, including automatic episode storage and physiologic trend data, which can be reviewed by clinicians and supports audit trails for continuous monitoring.

What are the key considerations for implementing each tool across multiple sites, and how do they ensure consistent workflow and data management in such scenarios?

BrightHeart's cloud-based, plug-and-play solution is designed for seamless integration into existing ultrasound workflows, facilitating consistent application and expert-level screening across various sites. The ASSURE system, with its wearable device, mobile application, and cloud-based Kestra CareStation, enables centralized remote patient data management, supporting consistent monitoring and data review across multiple care settings.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring BrightHeart View Classifier or ASSURE Wearable ECG

Backers

Who funded each tool's parent company.

BrightHeart View Classifier

ASSURE Wearable ECG

Longitude Capital